ArticleThe Journal of pharmacology and experimental therapeutics2015

New pyripyropene A derivatives, highly SOAT2-selective inhibitors, improve hypercholesterolemia and atherosclerosis in atherogenic mouse models.

Taichi Ohshiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.